Combining Clinical Parameters and Immunohistochemical Markers Might Strengthen Prediction of Recurrence of Non-Muscle Invasive Bladder Cancer

J Invest Surg. 2022 May;35(5):1195. doi: 10.1080/08941939.2022.2047244. Epub 2022 Mar 6.

Author

Senol Tonyali¹

Affiliation

¹ Department of Urology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.

PMID: 35249424
DOI: 10.1080/08941939.2022.2047244

No abstract available

MeSH terms

Biomarkers
Female
Humans
Male
Neoplasm Invasiveness
Urinary Bladder Neoplasms* / diagnosis
Urinary Bladder Neoplasms* / surgery

Substances

Biomarkers